| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |